Baillie Gifford & CO Ginkgo Bioworks Holdings, Inc. Call Options Transaction History
Baillie Gifford & CO
- $126 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DNA
# of Institutions
263Shares Held
912MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.11 Billion0.0% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$560 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$337 Million0.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny31.4MShares$252 Million0.02% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $10.3B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...